Rubix LS Rubix Life Sciences
Menu Button

Rubix LS

Delivering precision insight to create precision therapeutics with inclusive patient data

Connecting and powering the world's healthcare data through diversity patient analytics

Precision health research data points

19
Countries Supported
1,982
Disease & Cancers Supported

Precision Trial Program Delivery

Using data and digital health to translate programs and facilitating the clinical research delivery to accelerate research to overcome disease and cancer health disparities

01

Characterize big data sets along with patient trends.

02

Using precision intelligence, design and optimize clinical research to underserved communities using patient centric methodologies.

03

As lead CRO/complementary partner, we deploy our team and tools in communities to recruit, engage and conduct remote monitoring for patients while supplying data.

04

Prepare documentation packaging and submissions for sponsor, regulatory agencies, institutions while supporting future healthcare post market delivery integrations

Data Analytics

Intelligence/RWE

Ops/Strategy

Clinical Research Delivery

Research Aggregation/Care Delivery

Enable Programmatic Processes
to drive Patient Inclusivity within
the spectrum of clinical Research


Data Analytics

Intelligence/RWE

Ops/Strategy

Clinical Research Delivery

Research Aggregation/Care Delivery

Working through roadblocks to bring
inclusivity into early & late stage trials
with precision outcomes for all
Taking the blended data streams of patient,
disease, environment and sociological
factors to design science outcomes
As either a lead or complementary
partner we're designing efficient methods
to be where the patients are
Operating to ensure your endpoints are
met with scaling diversity metrics
From data aggregated from the trials -
we're designing and creating sustaining
systems to care for patients after
trial concludes

Specialties

Uncovering the holistic picture to determine best paths of cancer and disease causes while developing targeted precision medicine strategies

Infectious Disease

Infectious Disease

Rare & Ultra Rare

Rare & Ultra Rare

Environmental

Environmental

Oncology

Oncology

Rubix LS Nominated for Prestigious DEI Award

Rubix LS is among an illustrious group of finalists for an award in the Diversity and Inclusion (DI) Champions category from the BWB Awards, recognizing excellence and leadership in the healthcare industry, the company announced last week. As part of Biotech Week Boston, the award ceremony highlights innovative achievements from...

Had Covid-19 Ushered in the Era of Telemedicine?

Suppose the Covid-19 pandemic possessed any kind of silver lining. In that case, it could be that telehealth and many related tools and technologies appear to have passed the performance audition under stressful conditions, notes a white paper from Rubix, “Hospitals Adapting to Health Techniques for Patient Monitoring for Disease...

Care Disparities Put Minority Populations at Risk of Significant Neurodegenerative Threats

A cruel irony exists in the healthcare ecosystem of the United States: Proliferative Neurodegenerative conditions may occur more often in black, indigenous, and people of color patient populations even as they are underdiagnosed by well-meaning but ill-equipped healthcare professionals, says a new report from Rubix, “Understanding Neurodegenerative Cases and how...